Boston Scientific Corporation is recalling approximately 26,570 units (1,333 in the US and 25,174 internationally) of the Carotid WALLSTENT Monorail Endoprosthesis. This medical device, which includes both the carotid stent and its delivery system, is being removed from the market following reports of physicians encountering unexpected resistance while trying to withdraw the delivery system after the stent was successfully deployed. The recall affects specific material numbers and batches manufactured in the United States and distributed worldwide, including Puerto Rico.
If the stent delivery system encounters resistance during withdrawal, it may cause a delay in the medical procedure or damage to the blood vessel, such as injury or spasms. In the most severe cases, this issue can lead to a stroke or require additional surgical intervention to correct damage to the stent or vessel.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.